Trident Lifeline Limited
Bookbuilding IPO · BSE
- Price band
- ₹101 - ₹101
- Lot size
- 1,200 shares
- Issue amount
- ₹35.34 cr
- Total subscription
- 1.34×
- Opens
- 26 Sept 2022
- Closes
- 29 Sept 2022
- Allotment
- 4 Oct 2022
- Listing
- 10 Oct 2022
Offer at a glance
Issue overview
- Issue size
- 34,99,200 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,21,200
- Fresh issue
- ₹35.34 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,21,200
- Issue type
- Bookbuilding IPO
- Shares before issue
- 80,00,000
- Shares after issue
- 1,14,99,200
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,21,200 |
| HNI | 2 | 2,400 | ₹2,42,400 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing and distribution of pharmaceutical products in domestic and international markets through a third-party distribution network. The company offers a portfolio of 832 products as of May 31, 2022, including antibiotics, antifungals, antimalarials, antidiabetics, dental care products, proton pump inhibitors, antihistamines, antihypertensives, antiparasitics, multivitamins, multiminerals, and NSAIDs. Its core business includes ethical marketing of pharmaceutical formulations internationally under its brand and sourcing approved formulations through contract manufacturers for both domestic and global markets. Trident Lifeline has a presence in India as well as in African, Latin American, and East Asian countries, with registered or under-registration products in Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Promoters
Mr. Hardik Jigishkumar Desai
Mr. Mayurkumar Mansukhbhai Gajera
Mrs. Rupaben C Jariwala
Mrs. Rinkal Mayurbhai Gajera
Mr. Tarang Nathabhai Gajera
Mr. Mohak Nathabhai Gajera
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
2nd Floor, Shop-2004, North Extension, Falsawadi Begumpura, Nodh-4/1650, Sahara Darwaja, Surat – 395003
8160276395
[email protected]Company website ↗Understanding TLL IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.